Churchill Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-139,656
Closed -$12.5M 163
2025
Q1
$12.5M Buy
+139,656
New +$12.5M 0.16% 55
2019
Q2
Sell
-15,887
Closed -$1.45M 117
2019
Q1
$1.45M Buy
15,887
+6,088
+62% +$545K 0.04% 98
2018
Q4
$891K Buy
+9,799
New +$916K 0.04% 89
2015
Q3
Sell
-25,796
Closed -$1.91M 163
2015
Q2
$1.91M Sell
25,796
-1,079
-4% -$82.4K 0.07% 122
2015
Q1
$2.1M Sell
26,875
-2,409
-8% -$183K 0.07% 120
2014
Q4
$2.11M Sell
29,284
-1,081
-4% -$75.1K 0.08% 117
2014
Q3
$1.88M Sell
30,365
-1,729
-5% -$110K 0.08% 118
2014
Q2
$2.05M Sell
32,094
-1,300
-4% -$79K 0.09% 105
2014
Q1
$2.06M Buy
33,394
+3,593
+12% +$209K 0.08% 104
2013
Q4
$1.71M Buy
29,801
+12,649
+74% +$717K 0.07% 108
2013
Q3
$913K Buy
17,152
+8,044
+88% +$433K 0.05% 117
2013
Q2
$469K Buy
+9,108
New +$450K 0.02% 137

Other funds holding MDT

Churchill Management's MDT Position: Q2 2025 in Review

Churchill Management sold out of Medtronic (MDT) in Q2 2025, closing a stake of 139,656 shares — an estimated $12.5M sold.

Churchill Management first reported a position in MDT in Q2 2013 and held it in 12 quarters. The position peaked at $12.5M in Q1 2025. 2,139 funds tracked by Wall St. Rank hold MDT as of Q2 2025.

  • Churchill Management reported no remaining Medtronic position as of Q2 2025 after selling out during the quarter.
  • Churchill Management sold 139,656 Medtronic shares in Q2 2025, an estimated $12.5M.
  • Churchill Management first reported a position in Medtronic in Q2 2013 and held it in 12 quarters.
  • Churchill Management's Medtronic position peaked at $12.5M in Q1 2025.
  • 2,139 funds tracked by Wall St. Rank held Medtronic as of Q2 2025.

Based on Churchill Management's 13F filing for Q2 2025, filed 18 Jul 2025.